The O2matic PRO from BOC is designed to quickly stabilise arterial oxygen saturation in patients suffering from conditions that can lead to respiratory distress.
ENA Respiratory is seeking 100 healthy Sydneysiders to participate in a phase I study of its anti-COVID-19 nasal spray.
In response to global shortages, Oxair is spreading the word about its off-the-shelf solution — Oxygen Pressure Swing Adsorption (PSA) systems.
Updates to the Australian Asthma Handbook will help health professionals advise patients with asthma during the COVID-19 vaccine rollout.
Australian researchers have found that the 2019–2020 bushfire season racked up smoke-related health costs of around $1.95 billion.
University of Leeds researchers have identified a pattern of long-term symptoms experienced by people hospitalised with COVID-19.
Dr Harrison Steel has been directly involved in two significant projects that have impacted the COVID-19 health crisis.
The National Asthma Council Australia has released a preview of the updated Australian Asthma Handbook V2.1.
The antiviral drug is the first medication to be recommended as a considered treatment for hospitalised patients with the condition.
A new self-administered treatment for severe eosinophilic asthma will be reimbursed by the Pharmaceutical Benefits Scheme from 1 June 2020.
A UK study has revealed that age, male sex, obesity and underlying illness emerge as risk factors for severe COVID-19 or death.
New insights into the molecular mechanisms driving mucus viscosity could help improve airway-clearing treatment options for patients with respiratory conditions.
Doctors are giving advice to the 2.7 million Australians with asthma about how the novel coronavirus affects them.
E-cigarettes containing nicotine are illegal in Australia. Some health experts believe they shouldn't be...
Are smokers more likely to contract COVID-19 than non-smokers? Are they likely to have worse outcomes? Two academics from UNSW Sydney discuss how coronavirus affects smokers.